H1N1 Influenza Center

From the Publishers of the New England Journal of Medicine

A Novel Influenza A (H1N1) Vaccine in Various Age Groups A Novel Influenza A (H1N1) Vaccine in Various Age Groups

Posted by NEJM Editors • October 21st, 2009 • Printer-friendly

ORIGINAL ARTICLE
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
F.-C. Zhu and Others

The administration of an inactivated vaccine against the 2009 H1N1 virus achieved typical protective immune responses after one dose in subjects between 12 and 60 years of age, whereas two doses were required for younger subjects (3 to 11 years of age).

Full Text | PDF | Supplementary Material


Tagged as: , , ,

Leave a Response


Please note: comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Submitting a comment indicates you have read and agreed to the Terms and Conditions.

RSS NEJM Collections: Global Health

RSS NEJM Collections: Infectious Diseases

RSS Physician’s First Watch